How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
The scientist who won a Nobel prize for her work in first identifying HIV says she at last believes finding a cure for the virus which causes Aids might be possible.
French virologist Francoise Barre-Sinoussi said she could not put a timescale on when it might be found but scientists were developing promising new tools.
Over 30 million people have died from HIV/AIDS since it was first identified in 1981.
Since then there has been a number of prevention and treatment breakthroughs so that people with HIV can expect to live a relatively normal lifespan - providing they have access to the correct drugs.
"The reason why we are talking about a cure today is because we have some evidence that it might be possible," Professor Barre-Sinoussi told Tim Franks on the BBC's HARDtalk programme.
Until recently medical researchers had virtually given up the pursuit of a cure but the experiences of two patients now suggest to many scientists that it may be achievable.
'Proof of concept'
One man, the so-called Berlin patient, apparently has cleared his HIV infection, albeit by arduous bone marrow transplants.
More recently, a 50-year-old man in Trenton, New Jersey, underwent a far less difficult gene therapy procedure.
While he was not cured, his body was able to briefly control the virus after he stopped taking the usual antiviral drugs, something that is highly unusual.
Professor Barre-Sinoussi said of the Berlin patient case: "It turns out today that after two bone marrow transplants we can say we cannot detect the virus anymore in his body.
"It is a proof of concept somehow that we did not have before."
There are two main approaches to finding a cure. One is to seek the complete eradication of HIV from the body. The other, a functional cure, would not eliminate the virus but would allow a person to remain healthy without antiviral drugs.
Currently a patient is required to take antiviral drugs every day. This is costly and drugs are not so readily available in poorer countries.
New tools
"The reason why we are pushing for a cure is the fact that we know it is a life-long treatment. We know that it is of course very difficult for universal access, for treatment for all.
"We know as well that there is a small proportion of patients that on long-term treatment are developing complications so that means we need to have new tools for the future," she said.
In 2008 she was awarded the Nobel Prize in Physiology or Medicine, together with her former mentor, Luc Montagnier, for their discovery of HIV.
She will shortly take up the post of President of the International Aids Society.
In her new role she will continue to be a stoic defender of funding for research which in many countries is under threat because of the economic climate.
She has in the past spoken of being "upset and furious" about cuts to international funding for tackling HIV.
While it is hoped securing funding for research will bring a cure for HIV closer, Professor Barre-Sinoussi is reluctant to commit herself as to how close we are in time to that moment that scientists have waited so long to arrive.
"I cannot answer this question if I am honest. A scientist should be honest in my opinion. We don't know."
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.